Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
NOT YET RECRUITING
NCT07501702
PHASE2
A Phase 2 Study to Evaluate Povetacicept in Adults With Generalized Myasthenia Gravis
Sponsor: Vertex Pharmaceuticals Incorporated
View on ClinicalTrials.gov
Summary
The purpose of this study is to evaluate the pharmacodynamic (PD) effect, safety, and tolerability of Povetacicept in participants with generalized myasthenia gravis (gMG).
Official title: A Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study With a Long-term Extension of Povetacicept in Adults With Generalized Myasthenia Gravis
Key Details
Gender
All
Age Range
18 Years - 80 Years
Study Type
INTERVENTIONAL
Enrollment
30
Start Date
2026-04-16
Completion Date
2029-03-02
Last Updated
2026-03-30
Healthy Volunteers
No
Conditions
Interventions
DRUG
Povetacicept
Solution for Subcutaneous Injection.
DRUG
Placebo
Solution for Subcutaneous Injection.